1. |
PARD6A |
ENSGALG00000001214 |
9 |
4 |
- |
- |
1.000 |
- |
1.000 |
1.000 |
- |
- |
- |
1.000 |
par-6 family cell polarity regulator alpha [Source:HGNC Symbol;Acc:HGNC:15943] |
2. |
FZD10 |
ENSGALG00000042003 |
11 |
1.657 |
- |
- |
- |
- |
- |
0.804 |
- |
- |
- |
0.853 |
frizzled class receptor 10 [Source:NCBI gene;Acc:373885] |
3. |
SPRY3 |
ENSGALG00000007448 |
1 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
sprouty RTK signaling antagonist 3 [Source:NCBI gene;Acc:428712] |
4. |
SLC39A3 |
ENSGALG00000020582 |
1 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
solute carrier family 39 member 3 [Source:HGNC Symbol;Acc:HGNC:17128] |
5. |
SNORD16 |
SNORD16 |
2 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
|
6. |
KIAA1199 |
KIAA1199 |
6 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
|
7. |
TM6SF2 |
ENSGALG00000029015 |
109 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
transmembrane 6 superfamily member 2 [Source:HGNC Symbol;Acc:HGNC:11861] |
8. |
RAB40B |
ENSGALG00000001545 |
8 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
RAB40B, member RAS oncogene family [Source:NCBI gene;Acc:417338] |
9. |
DFNB59 |
ENSGALG00000023439 |
4 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
deafness, autosomal recessive 59, transcript variant X1 |
10. |
COR7A |
COR7A |
3 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
|
11. |
ARSH |
ENSGALG00000016636 |
34 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
arylsulfatase family, member H [Source:NCBI gene;Acc:378798] |
12. |
MYPN |
ENSGALG00000003925 |
6 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
myopalladin [Source:HGNC Symbol;Acc:HGNC:23246] |
13. |
RAB41 |
ENSGALG00000026278 |
2 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
RAB41, member RAS oncogene family, transcript variant X2 |
14. |
SH3GL3 |
ENSGALG00000006045 |
12 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
SH3 domain containing GRB2 like 3, endophilin A3 [Source:NCBI gene;Acc:395201] |
15. |
NOG |
ENSGALG00000003114 |
12 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
noggin [Source:NCBI gene;Acc:373912] |
16. |
TMEM71 |
ENSGALG00000044996 |
4 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
transmembrane protein 71 [Source:HGNC Symbol;Acc:HGNC:26572] |
17. |
ENSGALG00000025856 |
ENSGALG00000025856 |
3 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
|
18. |
FBXO18 |
|
35 |
0.971 |
- |
- |
- |
- |
- |
0.971 |
- |
- |
- |
- |
F-box protein, helicase, 18, transcript variant X4 |
19. |
SPOCK2 |
|
9 |
0.959 |
- |
- |
- |
- |
- |
0.959 |
- |
- |
- |
- |
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2, transcript variant X2 |
20. |
ENSGALG00000028322 |
ENSGALG00000028322 |
19 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
21. |
LRP3 |
ENSGALG00000004853 |
13 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
LDL receptor related protein 3 [Source:HGNC Symbol;Acc:HGNC:6695] |
22. |
ERN1 |
ENSGALG00000003476 |
4 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
endoplasmic reticulum to nucleus signaling 1 [Source:NCBI gene;Acc:417414] |
23. |
TPPP3 |
ENSGALG00000002103 |
1 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
tubulin polymerization promoting protein family member 3 [Source:HGNC Symbol;Acc:HGNC:24162] |
24. |
CDH20 |
ENSGALG00000012906 |
2 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
cadherin 20, type 2 [Source:NCBI gene;Acc:373927] |
25. |
LMO3 |
ENSGALG00000036358 |
1 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
LIM domain only 3 [Source:HGNC Symbol;Acc:HGNC:6643] |
26. |
SLC6A11 |
ENSGALG00000004879 |
16 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
solute carrier family 6 member 11 [Source:HGNC Symbol;Acc:HGNC:11044] |
27. |
RHPN1 |
ENSGALG00000034337 |
3 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
rhophilin Rho GTPase binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19973] |
28. |
ENSGALG00000027815 |
ENSGALG00000027815 |
15 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
29. |
CDXB |
CDXB |
143 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
30. |
MYO18B |
ENSGALG00000045218 |
7 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
myosin XVIIIB [Source:HGNC Symbol;Acc:HGNC:18150] |
31. |
C9orf171 |
C9orf171 |
35 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
32. |
MYNN |
ENSGALG00000009409 |
11 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
myoneurin [Source:HGNC Symbol;Acc:HGNC:14955] |
33. |
IPP |
ENSGALG00000010287 |
2 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
intracisternal A particle-promoted polypeptide [Source:HGNC Symbol;Acc:HGNC:6108] |
34. |
GIF |
ENSGALG00000031546 |
2 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
gastric intrinsic factor [Source:HGNC Symbol;Acc:HGNC:4268] |
35. |
BPIFC |
BPIFC |
1 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
36. |
ENSGALG00000028571 |
ENSGALG00000028571 |
1 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
37. |
ENSGALG00000019221 |
ENSGALG00000019221 |
9 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
38. |
PSCA |
ENSGALG00000045875 |
5 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
prostate stem cell antigen [Source:HGNC Symbol;Acc:HGNC:9500] |
39. |
ENSGALG00000025714 |
ENSGALG00000025714 |
6 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
|
40. |
MLH1 |
ENSGALG00000039169 |
19 |
0.955 |
- |
- |
- |
- |
- |
0.955 |
- |
- |
- |
- |
mutL homolog 1 [Source:HGNC Symbol;Acc:HGNC:7127] |
41. |
GZF1_1 |
ENSGALG00000008350 |
92 |
0.954 |
- |
- |
- |
- |
- |
0.954 |
- |
- |
- |
- |
GDNF inducible zinc finger protein 1 [Source:HGNC Symbol;Acc:HGNC:15808] |
42. |
ASXL1 |
ENSGALG00000006612 |
273 |
0.953 |
- |
- |
- |
- |
- |
0.953 |
- |
- |
- |
- |
ASXL transcriptional regulator 1 [Source:HGNC Symbol;Acc:HGNC:18318] |
43. |
MIS18A |
ENSGALG00000015884 |
25 |
0.953 |
- |
- |
- |
- |
0.953 |
- |
- |
- |
- |
- |
MIS18 kinetochore protein A [Source:HGNC Symbol;Acc:HGNC:1286] |
44. |
ST3GAL4 |
ENSGALG00000029747 |
184 |
0.939 |
- |
- |
- |
- |
- |
0.939 |
- |
- |
- |
- |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:10864] |
45. |
SOX2 |
ENSGALG00000043460 |
6 |
0.938 |
- |
- |
- |
- |
- |
0.938 |
- |
- |
- |
- |
SRY-box 2 [Source:NCBI gene;Acc:396105] |
46. |
CADPS |
|
33 |
0.935 |
- |
- |
- |
- |
0.935 |
- |
- |
- |
- |
- |
calcium dependent secretion activator, transcript variant X19 |
47. |
MAGI3 |
ENSGALG00000001816 |
12 |
0.926 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.926 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 [Source:NCBI gene;Acc:419877] |
48. |
TMEM52B |
ENSGALG00000034698 |
169 |
0.91 |
- |
- |
- |
- |
- |
0.910 |
- |
- |
- |
- |
transmembrane protein 52B [Source:HGNC Symbol;Acc:HGNC:26438] |
49. |
GAREML |
GAREML |
8 |
0.909 |
- |
- |
- |
- |
- |
0.909 |
- |
- |
- |
- |
|
50. |
LOC769139 |
ENSGALG00000026754 |
753 |
0.908 |
- |
- |
- |
- |
- |
0.908 |
- |
- |
- |
- |
feather keratin 1-like, transcript variant X2 |
51. |
TMEM132B |
ENSGALG00000002742 |
122 |
0.904 |
- |
- |
- |
- |
- |
0.904 |
- |
- |
- |
- |
transmembrane protein 132B [Source:HGNC Symbol;Acc:HGNC:29397] |
52. |
ENSGALG00000007420 |
ENSGALG00000007420 |
7 |
0.9 |
- |
- |
- |
- |
- |
0.900 |
- |
- |
- |
- |
|
53. |
FAR1 |
ENSGALG00000005353 |
12 |
0.9 |
- |
- |
- |
- |
- |
0.900 |
- |
- |
- |
- |
fatty acyl-CoA reductase 1 [Source:NCBI gene;Acc:423028] |
54. |
BRINP2 |
ENSGALG00000004448 |
26 |
0.896 |
- |
- |
- |
- |
- |
0.896 |
- |
- |
- |
- |
BMP/retinoic acid inducible neural specific 2 [Source:HGNC Symbol;Acc:HGNC:13746] |
55. |
IRX5 |
ENSGALG00000003588 |
79 |
0.889 |
- |
- |
- |
- |
- |
0.889 |
- |
- |
- |
- |
iroquois homeobox 5 [Source:HGNC Symbol;Acc:HGNC:14361] |
56. |
GABPB2 |
ENSGALG00000026734 |
7 |
0.885 |
- |
- |
- |
- |
- |
0.885 |
- |
- |
- |
- |
GA binding protein transcription factor subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:28441] |
57. |
DOK6 |
ENSGALG00000013753 |
2 |
0.884 |
- |
- |
- |
- |
- |
0.884 |
- |
- |
- |
- |
docking protein 6 [Source:HGNC Symbol;Acc:HGNC:28301] |
58. |
ENSGALG00000024292 |
ENSGALG00000024292 |
2 |
0.881 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.881 |
|
59. |
MLANA |
ENSGALG00000019756 |
8 |
0.874 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.874 |
melan-A [Source:HGNC Symbol;Acc:HGNC:7124] |
60. |
CARD8 |
ENSGALG00000007698 |
45 |
0.874 |
- |
- |
- |
- |
- |
0.874 |
- |
- |
- |
- |
caspase recruitment domain family, member 8 |
61. |
UBXN6 |
ENSGALG00000001146 |
122 |
0.866 |
- |
- |
- |
- |
- |
0.866 |
- |
- |
- |
- |
UBX domain protein 6 [Source:HGNC Symbol;Acc:HGNC:14928] |
62. |
PTGS2 |
ENSGALG00000033635 |
426 |
0.865 |
- |
- |
- |
- |
- |
0.865 |
- |
- |
- |
- |
prostaglandin-endoperoxide synthase 2 [Source:NCBI gene;Acc:396451] |
63. |
ABCB5 |
ENSGALG00000010901 |
60 |
0.854 |
- |
- |
- |
- |
- |
0.854 |
- |
- |
- |
- |
ATP binding cassette subfamily B member 5, transcript variant X1 |
64. |
PLCD3 |
ENSGALG00000045212 |
5 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
phospholipase C delta 3 [Source:HGNC Symbol;Acc:HGNC:9061] |
65. |
KCNU1 |
ENSGALG00000045668 |
2 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
potassium calcium-activated channel subfamily U member 1 [Source:HGNC Symbol;Acc:HGNC:18867] |
66. |
CMTR2 |
ENSGALG00000002356 |
3 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
cap methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:25635] |
67. |
ENSGALG00000019202 |
ENSGALG00000019202 |
9 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
|
68. |
UNC5D |
ENSGALG00000001608 |
4 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
unc-5 netrin receptor D [Source:HGNC Symbol;Acc:HGNC:18634] |
69. |
CBLN1 |
ENSGALG00000042664 |
15 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
cerebellin 1 precursor [Source:HGNC Symbol;Acc:HGNC:1543] |
70. |
PTHRP |
PTHRP |
8 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
|
71. |
FOXO3 |
ENSGALG00000015297 |
1 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
forkhead box O3 [Source:HGNC Symbol;Acc:HGNC:3821] |
72. |
ANKFN1 |
ENSGALG00000003105 |
15 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
ankyrin repeat and fibronectin type III domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26766] |
73. |
XDH |
ENSGALG00000008701 |
10 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
xanthine dehydrogenase [Source:NCBI gene;Acc:396025] |
74. |
SLC26A4 |
ENSGALG00000007998 |
2 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
solute carrier family 26 member 4 [Source:HGNC Symbol;Acc:HGNC:8818] |
75. |
CISH |
ENSGALG00000002260 |
1 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
cytokine inducible SH2 containing protein [Source:NCBI gene;Acc:395335] |
76. |
TMEM204 |
ENSGALG00000029047 |
8 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
transmembrane protein 204 [Source:HGNC Symbol;Acc:HGNC:14158] |
77. |
RND2 |
ENSGALG00000002804 |
9 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
Rho family GTPase 2 [Source:NCBI gene;Acc:428307] |
78. |
ENSGALG00000023464 |
ENSGALG00000023464 |
3 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
|
79. |
VANGL1 |
ENSGALG00000015025 |
67 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
VANGL planar cell polarity protein 1 [Source:HGNC Symbol;Acc:HGNC:15512] |
80. |
PID1 |
ENSGALG00000002963 |
2 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
phosphotyrosine interaction domain containing 1 [Source:NCBI gene;Acc:424787] |
81. |
IRX4 |
ENSGALG00000022896 |
18 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
iroquois homeobox 4 [Source:NCBI gene;Acc:373974] |
82. |
OLIG3 |
ENSGALG00000013862 |
51 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
oligodendrocyte transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:18003] |
83. |
SLC46A2 |
ENSGALG00000027345 |
1 |
0.853 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.853 |
solute carrier family 46 member 2 [Source:HGNC Symbol;Acc:HGNC:16055] |
84. |
NDST3 |
|
22 |
0.848 |
- |
- |
- |
- |
0.848 |
- |
- |
- |
- |
- |
N-deacetylase and N-sulfotransferase 3, transcript variant X11 |
85. |
NEU2 |
ENSGALG00000037467 |
34 |
0.843 |
- |
- |
- |
- |
0.843 |
- |
- |
- |
- |
- |
neuraminidase 2 [Source:HGNC Symbol;Acc:HGNC:7759] |
86. |
CCDC92 |
ENSGALG00000003146 |
40 |
0.839 |
- |
- |
- |
- |
- |
0.839 |
- |
- |
- |
- |
coiled-coil domain containing 92 [Source:HGNC Symbol;Acc:HGNC:29563] |
87. |
ECEL1 |
ENSGALG00000030420 |
670 |
0.838 |
- |
- |
- |
- |
- |
0.838 |
- |
- |
- |
- |
endothelin converting enzyme like 1 [Source:HGNC Symbol;Acc:HGNC:3147] |
88. |
SV2C |
ENSGALG00000014967 |
7 |
0.835 |
- |
- |
- |
- |
- |
0.835 |
- |
- |
- |
- |
synaptic vesicle glycoprotein 2C [Source:HGNC Symbol;Acc:HGNC:30670] |
89. |
NKAIN3 |
NKAIN3 |
802 |
0.827 |
- |
- |
- |
- |
- |
0.827 |
- |
- |
- |
- |
|
90. |
FMNL2 |
ENSGALG00000012525 |
78 |
0.824 |
- |
- |
- |
- |
- |
0.824 |
- |
- |
- |
- |
formin like 2 [Source:HGNC Symbol;Acc:HGNC:18267] |
91. |
CBFA2T2 |
ENSGALG00000003096 |
61 |
0.82 |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
- |
CBFA2/RUNX1 translocation partner 2 [Source:NCBI gene;Acc:419155] |
92. |
MLXIP |
ENSGALG00000004397 |
125 |
0.819 |
- |
- |
- |
- |
- |
0.819 |
- |
- |
- |
- |
MLX interacting protein [Source:HGNC Symbol;Acc:HGNC:17055] |
93. |
MMD2 |
ENSGALG00000004530 |
167 |
0.817 |
- |
- |
- |
- |
- |
0.817 |
- |
- |
- |
- |
monocyte to macrophage differentiation associated 2 [Source:HGNC Symbol;Acc:HGNC:30133] |
94. |
POPDC2 |
ENSGALG00000014988 |
281 |
0.816 |
- |
- |
- |
- |
- |
0.816 |
- |
- |
- |
- |
popeye domain containing 2 [Source:NCBI gene;Acc:404229] |
95. |
SPIRE2 |
ENSGALG00000000521 |
26 |
0.816 |
- |
- |
0.816 |
- |
- |
- |
- |
- |
- |
- |
spire type actin nucleation factor 2 [Source:HGNC Symbol;Acc:HGNC:30623] |
96. |
TCAIM |
ENSGALG00000011498 |
30 |
0.814 |
- |
- |
- |
- |
- |
0.814 |
- |
- |
- |
- |
T-cell activation inhibitor, mitochondrial [Source:NCBI gene;Acc:420670] |
97. |
ENSGALG00000023852 |
ENSGALG00000023852 |
31 |
0.812 |
- |
- |
- |
- |
- |
0.812 |
- |
- |
- |
- |
|
98. |
DSL1 |
DSL1 |
113 |
0.811 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.811 |
|
99. |
CELSR3 |
ENSGALG00000036763 |
4 |
0.803 |
- |
- |
- |
- |
- |
0.803 |
- |
- |
- |
- |
cadherin EGF LAG seven-pass G-type receptor 3 [Source:HGNC Symbol;Acc:HGNC:3230] |
100. |
ENSGALG00000001346 |
ENSGALG00000001346 |
233 |
0.802 |
- |
- |
- |
- |
- |
0.802 |
- |
- |
- |
- |
|